Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Dec;6(6):1326-1330.
doi: 10.1002/ehf2.12508. Epub 2019 Sep 7.

Hypertrophic cardiomyopathy in a lupus patient: a case of hydroxychloroquine cardiotoxicity

Affiliations
Case Reports

Hypertrophic cardiomyopathy in a lupus patient: a case of hydroxychloroquine cardiotoxicity

Amanda Chang et al. ESC Heart Fail. 2019 Dec.

Abstract

Hydroxychloroquine (HCQ) is a well-established and effective immunomodulatory therapy for systemic lupus erythematosus and other autoimmune diseases. While retinal toxicity is a well-recognized complication, cardiotoxicity is lesser known. This case consists of a 63-year-old Filipina on chronic HCQ treatment that led to severe biventricular hypertrophy, increased filling pressure, systemic and pulmonary hypertension, and elevated brain natriuretic peptide. Genetic testing ruled out lysosomal storage disorders but revealed five rare variants of uncertain significance, including one that was temporarily re-classified as likely pathogenic. Endomyocardial biopsy demonstrated myeloid bodies admixed with curvilinear bodies, most consistent with a diagnosis of HCQ toxicity. This case illustrates the importance of clinical integration of multiple causes of cardiomyopathy, recognition of HCQ cardiotoxicity, and increased uncertainty in genetic test findings among racial minorities.

Keywords: Hydroxychloroquine; Hypertrophic cardiomyopathy; Minority; Myeloid bodies; Variant of uncertain significance.

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

Figure 1
Figure 1
Electrocardiogram demonstrated findings consistent with left ventricular hypertrophy. Twelve‐lead electrocardiograms demonstrated voltage criteria for left ventricular hypertrophy and prominent anterolateral horizontal ST depression and T wave inversion (A). One year later, the patient developed atrial fibrillation (B).
Figure 2
Figure 2
Cardiac magnetic resonance imaging demonstrated hypertrophic cardiomyopathy phenotype. Cardiac magnetic resonance imaging demonstrated normal left ventricular size and left ventricular hypertrophy and mildly dilated right and left atria (A) and dilated pulmonary artery measuring (B).
Figure 3
Figure 3
Cardiac endomyocardial biopsy demonstrated histological findings consistent with hydroxychloroquine cardiotoxicity. (A) Haematoxylin and eosin stain demonstrated diffusely vacuolated myocytes, scale bar = 50 μm. Ultrastructural evaluation by electron microscopy demonstrated (B) intracellular accumulation of myeloid bodies (star) and curvilinear bodies (arrow) and vacuoles containing electron‐dense autophagolysosomes (C); evaluation, original magnification ×16 000.

Similar articles

Cited by

References

    1. Marmor MF, Kellner U, Lai TY, Melles RB, Mieler WF. American Academy of O. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 Revision). Ophthalmology 2016; 123: 1386–1394. - PubMed
    1. Costedoat‐Chalumeau N, Hulot JS, Amoura Z, Delcourt A, Maisonobe T, Dorent R, Bonnet N, Sablé R, Lechat P, Wechsler B, Piette JC. Cardiomyopathy related to antimalarial therapy with illustrative case report. Cardiology 2007; 107: 73–80. - PubMed
    1. Authors/Task Force members , Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, Hagege AA, Lafont A, Limongelli G, Mahrholdt H, McKenna WJ, Mogensen J, Nihoyannopoulos P, Nistri S, Pieper PG, Pieske B, Rapezzi C, Rutten FH, Tillmanns C, Watkins H. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2014; 35: 2733–2779. - PubMed
    1. Joyce E, Fabre A, Mahon N. Hydroxychloroquine cardiotoxicity presenting as a rapidly evolving biventricular cardiomyopathy: key diagnostic features and literature review. Eur Heart J Acute Cardiovasc Care 2013; 2: 77–83. - PMC - PubMed
    1. Melles RB, Marmor MF. The risk of toxic retinopathy in patients on long‐term hydroxychloroquine therapy. JAMA Ophthalmol 2014; 132: 1453–1460. - PubMed

Publication types

MeSH terms

LinkOut - more resources